SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-24-108067
Filing Date
2024-10-11
Accepted
2024-10-11 16:33:34
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 tm2415452-18_424b4.htm 424B4 3796354
2 GRAPHIC lg_camp4-4c.jpg GRAPHIC 22380
3 GRAPHIC ph_identify-4c.jpg GRAPHIC 113569
4 GRAPHIC fc_ourpipeline-4c.jpg GRAPHIC 54405
5 GRAPHIC ph_geneexpression-4c.jpg GRAPHIC 80049
6 GRAPHIC bc_functionaldisorder-4c.jpg GRAPHIC 39549
7 GRAPHIC ph_sodiumacetate-4c.jpg GRAPHIC 59631
8 GRAPHIC pc_ucdpatient-4c.jpg GRAPHIC 51469
9 GRAPHIC bc_concentration-4c.jpg GRAPHIC 95842
10 GRAPHIC lc_ureaproduction-4clr.jpg GRAPHIC 56296
11 GRAPHIC lc_ammonialevel-4c.jpg GRAPHIC 97709
12 GRAPHIC lc_ammoniaureagen-4clr.jpg GRAPHIC 53186
13 GRAPHIC bc_ucdmrna-4clr.jpg GRAPHIC 52651
14 GRAPHIC lc_ureagenesisauc-4c.jpg GRAPHIC 47340
15 GRAPHIC fc_clinicaltrialdesign-4c.jpg GRAPHIC 65785
16 GRAPHIC lc_syngap1brainsofmice-4clr.jpg GRAPHIC 59394
17 GRAPHIC lc_humanneurons-4c.jpg GRAPHIC 56220
  Complete submission text file 0001104659-24-108067.txt   5170919
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B4 | Act: 33 | File No.: 333-282241 | Film No.: 241367918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)